TNFα polymorphisms and risk of psoriatic arthritis

Background: Tumour necrosis factor α (TNFα) is a cytokine of critical importance in psoriatic arthritis. Objectives: (1) To examine the association between TNFα promoter gene polymorphisms and psoriatic arthritis in two well characterised Canadian populations with the disease; (2) to carry out a meta-analysis of all TNFα association studies in white psoriatic arthritis populations. Methods: DNA samples were genotyped for five TNF variants by time of flight mass spectrometry using the Sequenom platform. All five single nucleotide polymorphisms were in the 5′ flanking region of TNFα gene at the following positions: −1031 (T→C), −863 (C→A), −857 (C→T), −308 (G→A), and −238 (G→A). Primary analyses were based on logistic regression. Summary estimates of disease/genotype relations from several studies were derived from random effects meta-analyses. Results: 237 psoriatic arthritis subjects and 103 controls from Newfoundland and 203 psoriatic arthritis subjects and 101 controls from Toronto were studied. A combined analysis of data from both populations, showed a significant association between disease status and the −238(A) variant (p = 0.01). The meta-analysis estimate for the −238(A) TNFα variant in eight psoriatic arthritis populations was also significant (odds ratio = 2.29 (95% confidence interval, 1.48 to 3.55)). Conclusions: Analysis of TNFα variants in psoriatic arthritis populations shows that the −238 (A) variant is a significant risk factor for this disease.

[1]  S Gary Firestein,et al.  Kelley's Textbook of Rheumatology , 2004 .

[2]  D. Kane,et al.  Tumor necrosis factor-α in psoriasis and psoriatic arthritis: A clinical, genetic, and histopathologic perspective , 2004, Current rheumatology reports.

[3]  D. Pisetsky,et al.  Associations, populations, and the truth: recommendations for genetic association studies in Arthritis & Rheumatism. , 2004, Arthritis and rheumatism.

[4]  P. Mease.  TNFα therapy in psoriatic arthritis and psoriasis , 2004 .

[5]  A. Bowcock,et al.  The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. , 2004, Human molecular genetics.

[6]  B. Bresnihan,et al.  Cytokine gene polymorphisms: association with psoriatic arthritis susceptibility and severity. , 2003, Arthritis and rheumatism.

[7]  Thomas A Trikalinos,et al.  Genetic associations in large versus small studies: an empirical assessment , 2003, The Lancet.

[8]  D. Sharp.  Acrylamide in food , 2003, The Lancet.

[9]  C. López-Larrea,et al.  MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. , 2002, The Journal of rheumatology.

[10]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[11]  E. Märker-Hermann,et al.  Differential association of polymorphisms in the TNFα region with psoriatic arthritis but not psoriasis , 2002, Annals of the rheumatic diseases.

[12]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[13]  R. Segal,et al.  Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. , 2001, Human immunology.

[14]  M. Muto,et al.  Lack of Association Between Promoter Polymorphism of the Tumor Necrosis Factor-α Gene and Psoriatic Arthritis in Japanese Patients , 2000 .

[15]  G. Illei,et al.  Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. , 2000, Arthritis and rheumatism.

[16]  D J Schaid,et al.  Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. , 1999, American journal of epidemiology.

[17]  P. Sasieni.  From genotypes to genes: doubling the sample size. , 1997, Biometrics.

[18]  E. Märker-Hermann,et al.  A TNF-α Promoter Polymorphism Is Associated with Juvenile Onset Psoriasis and Psoriatic Arthritis , 1997 .

[19]  B. Leeb,et al.  Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. , 1997, The Journal of rheumatology.

[20]  L. Excoffier,et al.  Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.

[21]  V. Wright,et al.  Familial occurrence of psoriatic arthritis. , 1973, Annals of the rheumatic diseases.

[22]  I. König,et al.  Association of TNF -238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. , 2005, The Journal of investigative dermatology.

[23]  K. Welsh,et al.  Tumour necrosis factor-a polymorphism and the HLA-Cw * 0602 allele in psoriatic arthritis , 2002 .

[24]  K. Welsh,et al.  Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. , 2002, Rheumatology.

[25]  M. Muto,et al.  Lack of association between promoter polymorphism of the tumor necrosis factor-alpha gene and psoriatic arthritis in Japanese patients. , 2000, The Journal of investigative dermatology.